Trial Profile
Incidence of outer retinal tubulation in ranibizumab-treated patients with age-related macular degeneration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Adverse reactions
- 17 Nov 2015 New trial record